Katy Holloway

Katy Holloway is a Professor of Criminology at the University of South Wales. She obtained her PhD from the University of Cambridge in 2000 and moved to Wales as a Research Fellow in 2002. Since completing her PhD, Katy's academic career has been focused on issues related to substance use. Originally, her primary research interest was on the link between drug use and crime. Over time, however, she has become far more interested in the people who use different substances and of finding ways to help keep them alive and reduce drug and alcohol-related harm.

Katy has published widely in the field of substance use (80+ publications) and has secured more than £1.5m of external grant funding. She is currently working on several research projects including: an evaluation of Buvidal (long-acting injectable buprenorphine); an assessment of the impact of Minimum Pricing for Alcohol in Wales; and a Health Care Research Wales funded project investigating substance use during periods of imprisonment and in the critical period immediately following release.

Katy is Director of the Substance Use Research Group at the University of South Wales and is a member of a range of advisory boards and steering groups. This includes Welsh Government's National Implementation Board for Drug Poisoning Prevention and the Western Bay Drugs Commission.